[Federal Register Volume 62, Number 39 (Thursday, February 27, 1997)]
[Notices]
[Page 8994]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-4896]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 21, 1996, and published in the Federal 
Register on November 14, 1996, (61 FR 58424), Nycomed, Inc., 33 
Riverside Avenue, Rensselaer, New York 12144, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of meperidine (9230), a basic class of 
controlled substance listed in Schedule II.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Nycomed, Inc. to 
manufacture meperidine is consistent with the public interest at this 
time. Therefore, pursuant to 21 U.S.C. Sec. 823 and 28 CFR Secs. 0.100 
and 0.104, the Deputy Assistant Administrator, Office of Diversion 
Control, hereby orders that the application submitted by the above firm 
for registration as a bulk manufacturer of the basic class of 
controlled substance listed above is granted.

    Dated: February 7, 1997.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-4896 Filed 2-26-97; 8:45 am]
BILLING CODE 4410-09-M